MedPath

T Wave Alternans in Hemodialysis

Completed
Conditions
End Stage Renal Disease
Coronary Heart Disease
Congestive Heart Failure
Registration Number
NCT00296543
Lead Sponsor
Indiana University School of Medicine
Brief Summary

The purpose of this study is to determine if the hemodialysis procedure changes the risk for cardiac arrest in patients.

Detailed Description

One-third to one-quarter of hemodialysis patients die of sudden cardiac death (SCD). The hemodialysis procedure may theoretically increase the risk of SCD. This study uses T wave alternans, a noninvasive marker of SCD, to objectively determine whether the hemodialysis procedure alters the risk of SCD in hemodialysis patients.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • 18 years of age or older
  • Normal sinus rhythm
Exclusion Criteria
  • Inability to give written informed consent
  • Active cardiac ischemia
  • Pacemaker
  • Inability to perform a brief walking treadmill test

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Indiana University School of Medicine

🇺🇸

Indianapolis, Indiana, United States

© Copyright 2025. All Rights Reserved by MedPath